Priporočila za preprečevanje in zdravljenje slabosti in bruhanja ob sistemskem onkološkem zdravljenju
Recommendations for prevention and treatment of nausea and vomiting in systemic oncology treatment
Keywords:
nausea, vomiting, oncological patients, systemic treatmentAbstract
Ni abstrakta.Abstract (Eng)
In spite of great advancement, nausea and vomiting remain the most common undesirable effects of systemic cancer treatment, which substantially lower the patients’ quality of life and reduce their compliance to continue systemic treatment. Recommendations for prevention and treatment of nausea and vomiting resulting from cytostatic treatment were published in 2003 in Oncology magazine. This article complements the recommendations for treatment of nausea and vomiting with new developments, which were published in the NCCN guidelines in 2014 and MASCC and ESMO in 2010 (1, 2). We present our method for treating dysphagia with the help of intraluminal oesophageal stents. In our practice, the intraluminal oesophageal stent has proven to be a very effective and the most patient-friendly method for optimal delivery of nutrients before and during neoadjuvant therapy. There are few complications, and insertions do not have a negative impact on the perioperative outcomes.Downloads
Published
How to Cite
Issue
Section
License
The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.
This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.